Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|January 11, 2022
Buccal Mucosa Cells as a Potential Diagnostic Tool to Study Onset and Progression of Arrhythmogenic CardiomyopathyHelen E Driessen, Stephanie M van der Voorn, Mimount Bourfiss, et al.
Human Pathology|October 5, 2016
A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parametersMargot M Koeneman, Freyja H M van Lint, Sander M J van Kuijk, et al.
Circulation. Arrhythmia and Electrophysiology|January 28, 2022
Integrating Exercise Into Personalized Ventricular Arrhythmia Risk Prediction in Arrhythmogenic Right Ventricular CardiomyopathyLaurens P Bosman, Weijia Wang, Øyvind H Lie, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 20, 2023
Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathyFreyja H M van Lint, Fahima Hassanzada, Tom E Verstraelen, et al.
Circulation. Genomic and Precision Medicine|August 7, 2019
Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De NovoFreyja H M van Lint, Brittney Murray, Crystal Tichnell, et al.
Circulation. Genomic and Precision Medicine|December 17, 2024
Recreational and Occupational Physical Activity and Risk of Adverse Events in Truncating MYBPC3 Founder Variant CarriersFahima Hassanzada, Mark Jansen, Freyja H M van Lint, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 1, 2024
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark studyMyrthe Y C van der Heide, Tom E Verstraelen, Freyja H M van Lint, et al.
European Heart Journal|June 11, 2021
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk predictionTom E Verstraelen, Freyja H M van Lint, Laurens P Bosman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 24, 2023
MYH7 p.(Arg1712Gln) is pathogenic founder variant causing hypertrophic cardiomyopathy with overall relatively delayed onsetLuisa Marsili, Freyja H M van Lint, Francesco Russo, et al.
JACC. Heart Failure|August 9, 2025
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive IndividualsMyrthe Y C van der Heide, Tom E Verstraelen, Remco de Brouwer, et al.
Pageof 2